9NH9 | pdb_00009nh9

Crystal Structure of N-oxygenase HrmI with the diferric cofactor and the N(6)-hydroxy-L-lysine product bound


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.96 Å
  • R-Value Free: 
    0.212 (Depositor), 0.212 (DCC) 
  • R-Value Work: 
    0.180 (Depositor), 0.180 (DCC) 
  • R-Value Observed: 
    0.181 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9NH9

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

The Heme Oxygenase-Like Diiron Enzyme HrmI Reveals Altered Regulatory Mechanisms for Dioxygen Activation and Substrate N-Oxygenation.

Skirboll, S.S.Gangopadhyay, M.Phan, H.N.Hartsell, J.Mudireddy, A.Hilovsky, D.Swartz, P.D.Liu, X.Guo, Y.Makris, T.M.

(2025) J Am Chem Soc 147: 30210-30221

  • DOI: https://doi.org/10.1021/jacs.5c08814
  • Primary Citation Related Structures: 
    9N1A, 9N1E, 9N1X, 9N2A, 9NH9

  • PubMed Abstract: 

    Nonheme diiron enzymes activate dioxygen (O 2 ) to affect various biochemical outcomes. HrmI, a member of the recently discovered and functionally versatile heme oxygenase-like dimetal oxidase/oxygenase (HDO) superfamily, catalyzes the N-oxygenation of L-Lysine to yield 6-nitronorleucine for the biosynthesis of the antibiotic hormaomycin. Unlike other characterized HDO N-oxygenases that have an additional carboxylate ligand thought to be key for regulating dioxygen activation and ensuing N-oxygenation, the predicted primary coordination sphere of HrmI resembles those of HDOs that instead perform C-C fragmentation of substrates. We show that diferrous HrmI reacts with O 2 in a substrate-independent manner to form a presumptive μ-1,2 (Fe 3+ ) 2 peroxo (or P ) intermediate common to the catalytic scheme of many HDOs. P is rapidly converted to a second species with both optical and Mössbauer properties that resemble an activated peroxodiferric adduct ( P' ). The substrate-dependent acceleration of P' decay suggests that it, rather than P , initiates l-Lysine metabolism. X-ray crystallographic studies of HrmI in several redox and ligand-bound states provide a stepwise view of structural changes during catalysis and, together with analytical approaches, capture a hydroxylamino metabolic intermediate en route to 6-nitronorleucine formation. The activation of peroxo species provides a key strategy that enables functional adaptation within the widely distributed HDO structural scaffold.


  • Organizational Affiliation
    • Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, North Carolina 27695, United States.

Macromolecule Content 

  • Total Structure Weight: 41.48 kDa 
  • Atom Count: 2,972 
  • Modeled Residue Count: 337 
  • Deposited Residue Count: 362 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
HrmI362Streptomyces griseoflavusMutation(s): 0 
UniProt
Find proteins for F8S6W0 (Streptomyces griseoflavus)
Explore F8S6W0 
Go to UniProtKB:  F8S6W0
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupF8S6W0
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.96 Å
  • R-Value Free:  0.212 (Depositor), 0.212 (DCC) 
  • R-Value Work:  0.180 (Depositor), 0.180 (DCC) 
  • R-Value Observed: 0.181 (Depositor) 
Space Group: P 32 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 112.52α = 90
b = 112.52β = 90
c = 67.315γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
CrysalisProdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM135315

Revision History  (Full details and data files)

  • Version 1.0: 2025-08-20
    Type: Initial release
  • Version 1.1: 2025-08-27
    Changes: Database references